The rearrangements of UBAP2L [35,36] and EHMT1 [35,36,37] have been reported in liver, lung, breast, ovary, and prostate cancer but not in hematological malignancies, and ABL1 or BCR has not been reported as their partner genes [35,36,37]. This evidence concerns the gene UBAP2L and prostate cancer.